{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["7(5)"],"submitter":["Thilly N"],"pubmed_abstract":["<h4>Importance</h4>The human papillomavirus (HPV) vaccine is safe and effective, yet vaccination coverage remains below public health objectives in many countries.<h4>Objective</h4>To examine the effectiveness of a 3-component intervention on HPV vaccination coverage among adolescents aged 11 to 14 years 2 months after the intervention ended, each component being applied alone or in combination.<h4>Design, setting, and participants</h4>A cluster randomized trial with incomplete factorial design (PrevHPV) was conducted between July 1, 2021, and April 30, 2022, in French municipalities receiving 0, 1, 2, or 3 components of the intervention. Randomization was stratified by school district and municipalities' socioeconomic level. Analyses were carried out on 11- to 14-year-old adolescents livi"],"journal":["JAMA network open"],"pagination":["e2411938"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11117086"],"repository":["biostudies-literature"],"pubmed_title":["Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial."],"pmcid":["PMC11117086"],"pubmed_authors":["Adam I","Hagiu DP","Simon M","Bonnay S","Zuo M","Barret AS","Thilly N","Ecollan M","Tron A","Lasset C","Simony M","Branchereau M","Bocquier A","Raude J","Le Bel J","Bruel S","Agrinier N","Botelho-Nevers E","Jambon G","Darlington E","Gagneux-Brunon A","Pinot J","Gauchet A","Marie Dit Asse L","Michel M","Mueller JE","Levy-Bruhl D","Le Duc-Banaszuk AS","Chyderiotis S","Partouche H","Oudin-Doglioni D","Giraudeau B","Bonmarin I","PrevHPV Study Group","Epaulard O","Rossignol L","Kalecinski J","Sicsic J","Nekaa M","Vareilles G","Ailloud J","Chevreul K","Gilberg S","Bros J","Castagnet C","Dussault J","Pulcini C","Jeanleboeuf F","Juneau C","Fall E"],"additional_accession":[]},"is_claimable":false,"name":"Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial.","description":"<h4>Importance</h4>The human papillomavirus (HPV) vaccine is safe and effective, yet vaccination coverage remains below public health objectives in many countries.<h4>Objective</h4>To examine the effectiveness of a 3-component intervention on HPV vaccination coverage among adolescents aged 11 to 14 years 2 months after the intervention ended, each component being applied alone or in combination.<h4>Design, setting, and participants</h4>A cluster randomized trial with incomplete factorial design (PrevHPV) was conducted between July 1, 2021, and April 30, 2022, in French municipalities receiving 0, 1, 2, or 3 components of the intervention. Randomization was stratified by school district and municipalities' socioeconomic level. Analyses were carried out on 11- to 14-year-old adolescents livi","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 May","modification":"2026-06-03T03:58:19.742Z","creation":"2026-04-24T03:09:51.185Z"},"accession":"S-EPMC11117086","cross_references":{"pubmed":["38780943"],"doi":["10.1001/jamanetworkopen.2024.11938"]}}